Evidence map›Paper›PMID 27051667›Full record

SynthesisBioMed research international2016

Covered Stents versus Uncovered Stents for Unresectable Malignant Biliary Strictures: A Meta-Analysis.

Ming-Yu Chen, Jia-Wei Lin, He-Pan Zhu, Bin Zhang, Guang-Yi Jiang, Pei-Jian Yan, Xiu-Jun Cai

Registry-linked trialOpen access · hybridAbstract readMeta-AnalysisReview
In one paragraph

Synthesis in BioMed research international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06453590 (Palliative Treatment of Distal Malignant Biliary Obstruction by Endoscopic Stents), which is not on this map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06453590 naactive not recruitingnot on this mapstarted 2020, after this paper: background citation

Palliative Treatment of Distal Malignant Biliary Obstruction by Endoscopic Stents: Uncovered, Partially Covered, or Fully Covered Metal Stents: A Prospective Randomized Multicenter Study

TypeinterventionalSponsorRegion StockholmRan2020 to 2027Enrolled450ConditionsPancreatic Cancer Non-resectable, Bile Duct Cancer, Papillary Carcinoma, Duodenal CancerArmsRandomization to uncovered SEMS treating jaundice due to distal malignant biliary obstruction., Randomization to partially covered SEMS treating jaundice due to distal malignant biliary obstruction., Randomization to fully covered SEMS treating jaundice due to distal malignant biliary obstruction.
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Optimization of biliary drainage in inoperable distal malignant strictures.World journal of gastrointestinal endoscopy · 2020
    Article
  15. Review
  16. Article
  17. The endoscopist and malignant and non-malignant biliary obstruction.Biochimica et biophysica acta. Molecular basis of disease · 2018
    Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ming-Yu ChenDepartment of General Surgery, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, China; Zhejiang University, Zhejiang 310020, China.
Jia-Wei LinZhejiang University, Zhejiang 310020, China.
He-Pan ZhuZhejiang University, Zhejiang 310020, China.
Bin ZhangZhejiang University, Zhejiang 310020, China.
Guang-Yi JiangZhejiang University, Zhejiang 310020, China.
Pei-Jian YanZhejiang University, Zhejiang 310020, China.
Xiu-Jun CaiDepartment of General Surgery, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, China; Zhejiang University, Zhejiang 310020, China.
Zhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo summarize the covered or uncovered SEMS for treatment of unresectable malignant distal biliary obstruction, comparing the stent patency, patient survival, and incidence of adverse events between the two SEMSs.

methodsThe meta-analysis search was performed independently by two of the authors, using MEDLINE, EMBASE, OVID, and Cochrane databases on all studies between 2010 and 2015. Pooled effect was calculated using either the fixed or the random effects model.

resultsStatistics shows that there is no difference between SEMSs in the hazard ratio for patient survival (HR 1.04; 95% CI, 0.92-1.17; P = 0.55) and stent patency (HR 0.87, 95% CI: 0.58 to 1.30, P = 0.5). However, incidence of adverse events (OR: 0.74, 95% CI: 0.57 to 0.97, P = 0.03) showed significant different results in the covered SEMS, with dysfunctions events (OR: 0.75, 95% CI: 0.56 to 1.00, P = 0.05) playing a more important role than complications (OR: 0.87, 95% CI: 0.58 to 1.30, P = 0.50).

conclusionsCovered SEMS group had lower incidence of adverse events. There is no significant difference in dysfunctions, but covered SEMS trends to be better, with no difference in stent patency, patient survival, and complications.

Indexed as

Biliary Tract Surgical ProceduresStentsAdultAgedAged, 80 and overBile Duct NeoplasmsCholestasisFemaleHumansMaleMiddle Aged

Identifiers

PMID27051667
PMCPMC4802019
OpenAlexW2293347890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.